Australia’s clinical trials sector spent $1.6 billion in 2022, providing cutting-edge therapies to 90,000 patients. With world-class infrastructure and regulatory standards, the industry is key to global medical research. Future priorities include streamlining approvals, expanding patient participation and growing the workforce, ensuring Australia remains at the forefront of innovation.
Discover more about Australia's role in advancing clinical trials.
